Company intelligence / Profile preview
Morepen Laboratories
Gurugram, Haryana, Indiamorepen.com ↗
- Ownership
- Private
- Employees
- ~2300
- Development stage
- Other
01
Overview
Morepen Laboratories has a robust commercial portfolio of APIs for major global markets with USFDA/EU GMP approvals. It supplies key APIs such as loratadine and montelukast to leading pharma companies worldwide. The company also manufactures finished formulations and a wide range of OTC/home diagnostic products for both domestic and international markets[1][2][3].
- Therapeutic areas
- PsychiatryPulmonologyInfectious DiseasesGastroenterologyEndocrinologyImmunologyCardiovascular
- Modalities
- Small moleculeDevice
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
ApotexNovex PharmaGenpharmNovopharmTechnilabImmucor USATeco Medical Instruments GermanyInTec Inc.Access Bio USA
Beyond the preview
Go deeper on Morepen Laboratories.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Morepen Laboratories.